Atea PharmaceuticalsAVIR

那斯達克 · USD
5.10
-0.11
(-2.11%)
收盤 10/02 03:58 (UTC+8)
10/02 03:58 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
35,09948,00854,93445,56741,34539,041----
研發費用
28,15041,13447,81838,34732,27529,58425,67126,15934,69657,575
推銷及管理費用
6,9496,8747,1167,2209,0709,45713,35511,04312,22012,231
非經常性項目費用
----------
其他營業費用
----------
營業利益
-35,099
-48,008
-54,934
-45,567
-41,345
-39,041
-39,026
-37,202
-46,916
-69,806
其他收入及費用
2,1902,6183,2993,7144,3914,9725,7086,2776,6376,868
利息費用
----------
稅前純益
-32,909
-45,390
-51,635
-41,853
-36,954
-34,069
-33,318
-30,925
-40,279
-62,938
所得稅
2450-6,768196207203225226243231
稅後純益
-32,933
-45,440
-44,867
-42,049
-37,161
-34,272
-33,543
-31,151
-40,522
-63,169
基本每股稅後盈餘(元)
-0.41-0.57-0.57-0.53-0.44-0.40-0.40-0.37-0.48-0.75
稀釋每股稅後盈餘(元)
-0.42-0.57-0.57-0.52-0.45-0.40-0.40-0.37-0.48-0.75
基本平均股數(千股)
80050.0079198.0078126.0079052.0083747.0085159.0084463.0084422.0084253.0083916.00
稀釋平均股數(千股)
80050.0079198.0078126.0079052.0083747.0085159.0084463.0084422.0084253.0083916.00
還原基本每股稅後盈餘(元)
-0.41-0.57-0.57-0.53-0.44-0.40-0.40-0.37-0.48-0.75
還原稀釋每股稅後盈餘(元)
-0.42-0.57-0.57-0.52-0.45-0.40-0.40-0.37-0.48-0.75
還原基本平均股數(千股)
80,05079,19878,12679,05283,74785,15984,46384,42284,25383,916
還原稀釋平均股數(千股)
80,05079,19878,12679,05283,74785,15984,46384,42284,25383,916
EBITDA(千元)
-33,347-45,867-52,339-42,824-38,171-35,705-35,927-33,417-43,199-66,322

大家都在看

HOT